Skip to Main Content

Paper Details

Overcoming adaptive therapy resistance in AML by targeting immune response pathways.
Sci Transl Med
50
2019
Author NameAffiliation
Xiaohu ZhangDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Donald D Lorimer
Craig J ThomasDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Craig J ThomasCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 4

Datasets